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SUMMARY
Oncogene-induced cellular senescence is well documented, but little is known about how infinite cell prolif-
eration induced by loss of tumor suppressor genes is antagonized by cellular functions. Rb heterozygous
mice generate Rb-deficient C cell adenomas that progress to adenocarcinomas following biallelic loss of
N-ras. Here, we demonstrate that pRb inactivation induces aberrant expression of farnesyl diphosphate
synthase,many prenyltransferases, and their upstream regulators sterol regulatory element-binding proteins
(SREBPs) in an E2F-dependent manner, leading to enhanced isoprenylation and activation of N-Ras. Conse-
quently, elevated N-Ras activity induces DNA damage response and p130-dependent cellular senescence
in Rb-deficient cells. Furthermore, Rb heterozygous mice additionally lacking any of Ink4a, Arf, or Suv39h1
generated C cell adenocarcinomas, suggesting that cellular senescence antagonizes Rb-deficient carcino-
genesis.INTRODUCTION
Carcinogenesis is induced by the breakdown of cellular func-
tions that counteract various oncogenic stimuli (Hanahan and
Weinberg, 2000). Oncogene-induced cellular senescence (OIS)
was first noted as paradoxical growth arrest in human diploid
fibroblasts induced by oncogenic Ras (Collado et al., 2007).
Currently, OIS is accepted as the cellular function that antago-
nizes carcinogenesis despite the presence of oncogenic muta-
tion. The study of melanocytic nevi carrying the BRAFV600E muta-
tion provided the first evidence of cellular senescence in human
premalignant lesions (Mooi and Peeper, 2006). Since then, the
number of identified OIS inducers has been increasing rapidly
(Di Micco et al., 2007).
OIS is achieved by activating tumor suppressors including
p16INK4a, ARF, pRB, and p53 or by inducing DNA damageresponse (DDR) activation engaged by gH2AX, Chk2, p53, and
ATM before critical telomeric attrition occurs (Collado et al.,
2007; Di Micco et al., 2007). These cellular functions counteract
infinite cell proliferation induced by oncogenic signals. Acceler-
ated cell proliferation induced by the loss of tumor suppressors
can be counteracted by similar functions. For example, PTEN
loss-induced prostate carcinogenesis is antagonized by p53-
mediated senescence (Chen et al., 2005), and VHL loss-induced
cellular senescence is mediated by pRB and p400 (Young et al.,
2008). In human retinoblastoma, additional aberration in the p53
pathway is required for carcinogenesis (Laurie et al., 2006).
Nevertheless, it is suspected that RB deficiency in the human
body can be antagonized in many ways because of the diversi-
fied functions of pRB and the limited variety of mouse and human
cell types that develop tumors with germline RB mutations
(Wikenheiser-Brokamp, 2006).SIGNIFICANCE
Aberration of the RB pathway critically pertains to human carcinogenesis. However, germline RBmutations are detected in
a limited variety of malignant tumors, implicating the presence of defense mechanisms antagonizing RB-deficient tumori-
genesis. In this study, we attempted to clarify the mechanism by which N-ras loci protect mouse C cells and primary fibro-
blasts from Rb loss-induced carcinogenesis and revealed a function of pRb in regulating posttranslational modification of
CAAXproteins. Our findings explain the tumor suppressor function of N-Ras in certain types of cells lacking pRb. In addition,
since Ras proteins promote carcinogenesis in many cell types, our findings may provide a rational basis for the application
of prenyltransferase inhibitors to human cancers with aberrations in the RB pathway.
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Rb Regulates Ras IsoprenylationRb+/ mice generate C cell adenoma in the thyroid following
somatic loss of the normal Rb allele. Additional loss of N-ras
alleles induces malignant conversion in Rb-deficient C cell
adenoma. Moreover, somatic N-ras loss frequently occurs in
Rb+/;N-ras+/ C cells following Rb loss, causing spontaneous
malignant conversion (Takahashi et al., 2006). The C cell tumor
phenotype observed in Rb+/;E2F3/ mice (Ziebold et al.,
Figure 1. Analysis of C Cell Tumors inRb+/;
N-ras+/+ and Rb+/;N-ras/ Mice
(A) Scheme of C cell carcinogenesis in Rb+/ mice
based on previous findings.
(B) Immunohistochemical (IHC) analysis and senes-
cence-associated b-galactosidase (SA-b-gal)
assay of thyroid and C cell tumors in mice of the
indicated genotypes. Twenty-two Rb+/;N-ras+/+
(average age at examination [AE] = 11.0 ± 1.2
months) and twenty-eight Rb+/;N-ras/ (AE =
10.6 ± 0.9 months) mice were analyzed. Scale
bars = 100 mm. The frequency of immunostain-
positive cells per 200 normal thyroid or tumor cells
is quantified at right. Bars show mean + SEM.
2003) is similar to that in Rb+/;N-ras/
mice. It has been proposed that the
Rb-E2F complex functions as a transcrip-
tional repressor to antagonize Ras
signaling during vulval formation in
Caenorhabditis elegans (Ceol and Hor-
vitz, 2001). The Rb-ras genetic interaction
during cell differentiation, embryogen-
esis, and tumorigenesis has been exten-
sively investigated in mice (Lee et al.,
1999; Takahashi et al., 2003, 2004,
2006); however, the core mechanism of
this interaction has not yet been clarified.
In this study, we sought in vitro and in vivo
evidence that Rb loss-induced cell
proliferation in mouse C cells and primary
fibroblasts is counteracted by an N-Ras-
dependent senescence pathway and
attempted to elucidate the mechanism
by which pRb regulates N-Ras activation.
RESULTS
N-ras-Dependent DDR and Cellular
Senescence in Rb-Deficient C Cell
Adenoma
To investigate how N-Ras prevents
Rb-deficient C cell adenoma from pro-
gressing to adenocarcinoma (Figure 1A),
we analyzed primary C cell tumors devel-
oped in Rb+/;N-ras+/+ (average age at
examination [AE] ± standard error of the
mean [SEM] = 11.0 ± 1.2 months) and
Rb+/;N-ras/ (AE = 10.6 ± 0.9 months)
mice. Proliferating cell nuclear antigen
(PCNA) and Ki-67 were frequently
expressed in Rb-deficient N-ras/
adenocarcinomas, but their expression was invariably rare in
Rb-deficient N-ras+/+ adenomas (Figure 1B). On the other
hand, Rb-deficient N-ras+/+ adenomas frequently expressed
DDR markers (Shiloh, 2003) including H2AX phosphorylated at
serine 139 (gH2AX), ATM phosphorylated at serine 1981
(ATMpS1981), and p53 phosphorylated at serine 15 (p53pS15).
These markers were rarely detected inN-ras/ adenocarcinomas
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Rb Regulates Ras Isoprenylation(Figure 1B). In addition, N-ras+/+ tumors frequently expressed
senescence markers (Dimri, 2005) including histone H3 trimethy-
lated at lysine 9 (H3K9me3), heterochromatin protein 1g (HP1g),
p16Ink4a, and senescence-associated b-galactosidase (SA-b-gal)
activity. These markers were rarely detected in N-ras/ adeno-
carcinomas (Figure 1B) or in adenocarcinomas spontaneously
developed in Rb+/;N-ras+/ mice as a consequence of somatic
N-ras allele loss following Rb loss (see Figure S1 available
A
B
C
Figure 2. CCell Tumor Phenotypes inRb+/MiceAddi-
tionally Lacking Senescence-Mediating Genes
(A) C cell tumors (indicated by arrows) developed in mice of the
indicated genotype and age (months). Scale bars = 3 mm.
(B)Histological and IHC analysis of C cell tumors in mice of the
indicated genotype and age (months). Scale bars = 100 mm.
(C)Calcitonin staining of cultured tumor cells prepared
from thyroids of mice of the indicated genotype. Scale
bars = 100 mm.
online). These findings suggest that N-ras loci
induce DDR and cellular senescence during
adenoma formation initiated by Rb loss. We there-
fore hypothesized that N-Ras preventsRb-deficient
C cell adenomas from progressing to adenocarci-
nomas by inducing DDR and cellular senescence.
To determine the sequence of events during
adenoma development, we compared Rb-deficient
adenomas developed in younger Rb+/ mice (early
adenoma; AE = 6.2 ± 0.3 months) to those in older
mice (late adenoma; AE = 11.0 ± 1.2 months).
DDR markers were expressed in early and late
adenomas with similar frequencies; however,
senescence markers were less frequently ex-
pressed in early adenomas (Figure S2). In contrast,
PCNA and Ki-67 were more frequently expressed in
early adenomas than in late adenomas. These
findings suggest that DDR may precede cellular
senescence during the development of C cell
adenoma initiated by Rb loss, and that early
adenomas grow even in the presence of DDR but
cease to grow when cellular senescence is induced.
Role of Senescence-Mediating Genes
in Rb-Deficient C Cell Adenoma
To examine whether cellular senescence protects
Rb-deficient C cell adenomas from progressing
to adenocarcinoma, we generated Rb+/ mice
simultaneously lacking Ink4a, Ink4a and Arf, Arf, or
Suv39h1. All Rb+/;Ink4a/ mice survived longer
than 8 months (n = 12). The average age at
onset of sickness or death (ASD) was 9.3 ± 0.4
months in Rb+/;Ink4a+/+ (n = 7), 9.5 ± 0.6 months
in Rb+/;Ink4a+/ (n = 3), and 9.7 ± 0.4 months in
Rb+/;Ink4a/ (n = 6) mice. No acceleration of
Rb-deficient pituitary tumorigenesis was observed
in the Ink4a/ background (data not shown). All
Rb+/;Ink4a/ mice exhibited large macroscopic
tumors stemming from the thyroid (Figure 2A;
Table 1). Rb+/;Ink4a+/ mice generated macro-
scopic tumors, but these were smaller than those in Rb+/;
Ink4a/ mice. No macroscopic thyroid tumors were observed
in Rb+/;Ink4a+/+ mice. Histologically, all thyroid tumors devel-
oped in Rb+/;Ink4a/ and Rb+/;Ink4a+/ mice exhibited
features of C cell adenocarcinoma (Figure 2B; Table 1) and were
similar to tumors developed in Rb+/;N-ras/ mice. Rb+/+;
Ink4a/ mice showed no evidence of microscopic thyroid
tumors. Rb-deficient Ink4a/ cells separated from primary
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Rb Regulates Ras IsoprenylationTable 1. Pathological Diagnosis of Thyroids Derived from Mice of the Indicated Genotypes
Genotype AE (months) n AD CA MD (mm) CEA (%) PCNA (%) Ki-67 (%)
Rb+/+;Ink4a+/+ 12.0 ± 1.0 5 0 0 – – – –
Rb+/;Ink4a+/+ 9.8 ± 0.4 9 8 0 1.0 ± 0.2 1.4 ± 0.2 5.4 ± 0.4 4.6 ± 1.7
Rb+/+;Ink4a/ 11.6 ± 0.4 3 0 0 – – – –
Rb+/;Ink4a+/ 10.0 ± 0.4 6 0 6 3.9 ± 0.2 66.3 ± 2.5 77.3 ± 2.0 74.7 ± 2.4
Rb+/;Ink4a/ 10.1 ± 0.3 8 0 8 8.6 ± 0.2 74.2 ± 2.0 84.2 ± 1.0 86.5 ± 1.8
Rb+/;Arf+/+;Ink4a+/+ 6.2 ± 0.5 8 2 0 0.2 ± 0.1 NA NA NA
Rb+/+;Arf/;Ink4a/ 6.8 ± 0.1 5 0 0 – – – –
Rb+/;Arf+/;Ink4a+/ 7.3 ± 0.2 5 0 5 1.9 ± 0.2 2.5 ± 0.2 78.8 ± 1.5 76.9 ± 2.2
Rb+/;Arf/;Ink4a/ 5.6 ± 0.3 6 0 6 3.5 ± 0.3 2.2 ± 0.3 82.4 ± 1.2 84.1 ± 1.6
Rb+/;Arf+/+ 5.4 ± 0.5 6 0 0 – – – –
Rb+/+;Arf/ 6.5 ± 1.0 6 0 0 – – – –
Rb+/;Arf+/ 6.5 ± 1.4 2 0 0 – – – –
Rb+/;Arf/ 5.2 ± 0.3 5 0 5 1.7 ± 0.1 2.1 ± 0.2 57.8 ± 2.3 55.6 ± 2.2
Rb+/;Suv39h1+/+ 4.8 ± 0.3 6 0 0 – – – –
Rb+/+;Suv39h1/ 4.8 ± 0 2 0 0 – – – –
Rb+/;Suv39h1+/ 5.0 ± 0 3 0 0 – – – –
Rb+/;Suv39h1/ 4.6 ± 0.2 8 0 8 3.6 ± 0.1 66.8 ± 2.3 81.1 ± 2.1 79.7 ± 2.3
Data shown include average age at examination (AE), number of analyzed thyroids (n), histological diagnosis of adenoma (AD) or carcinoma (CA), mean
diameter of tumors (MD), and percentage of CEA-, PCNA-, and Ki-67-positive cells in tumors. Data are shown as ± SEM. –, no data; NA, not analyzed.tumors grew in tissue culture and expressed calcitonin (5
successful cultures from 6 attempts with independent tumors)
(Figure 2C), as did Rb-deficient N-ras/ C cell adenocarcinoma
cells. However, no clonally expanding calcitonin-positive cells
were derived from thyroids harboring Rb-deficient Ink4a+/+
tumors (0 of 6), suggesting that, like Rb-deficient N-ras/ C
cells, Rb-deficient Ink4a/ C cell tumor cells had acquired the
ability to infinitely proliferate. Therefore, we diagnosed tumors
developed in Rb+/;Ink4a/ mice as C cell adenocarcinomas.
These findings suggest that C cell carcinogenesis initiated by
Rb loss is blocked by Ink4a.
Rb+/;Ink4a/;Arf/ (ASD = 5.3 ± 0.1 months; n = 9) and
Rb+/;Arf/ (ASD = 4.7 ± 0.2 months; n = 3) mice died of
lymphoma, sarcoma, or more often accelerated pituitary tumor
growth as described previously (Tsai et al., 2002) before they
developed macroscopic thyroid tumors. However, at 4.8 months,
Rb+/;Ink4a/;Arf/ mice developed large microscopic
adenocarcinomas with a morphology different from that of
Rb-deficient N-ras/ or Rb-deficient Ink4a/ tumors
(Figure 2B). Rb+/+;Ink4a/;Arf/ mice of the same age or older
showed no evidence of microscopic thyroid tumors (Table 1).
In Rb+/;Arf/ mice (AE = 5.2 ± 0.3 months), but not in Rb+/+;
Arf/ mice, we often observed large microscopic adenocarci-
nomas with morphologies different from those in Rb-deficient
N-ras/, Rb-deficient Ink4a/, or Rb-deficient Ink4a/;Arf/
tumors. Tumor cells separated from Rb+/;Ink4a/;Arf/ (3 of
3) and Rb+/;Arf/ (2 of 2) mice grew in tissue culture and
expressed calcitonin. However, in the Arf/ background,
regardless of Ink4a genotype and despite the frequent PCNA
and Ki-67 expression and infinite growth in culture, the frequency
of carcinoembryonic antigen (CEA)-positive C cell tumor cells
was low (Figure 2B; Table 1). This suggests a specific genetic
interaction between Arf and CEA. Rb+/;Suv39h1/ mice
(AE = 4.6 ± 0.2 months) exhibited macroscopic tumors (Figure 2A;258 Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc.Table 1) that grew in tissue culture (2 of 2) (Figure 2C) and fre-
quently expressed CEA, PCNA, and Ki-67 (Figure 2B; Table 1).
These findings suggest that p16Ink4a, Arf, and Suv39h1 antago-
nize Rb-deficient C cell carcinogenesis.
Role of N-Ras in Rb-Deficient C Cell Carcinogenesis
We generated 11 cell lines from independent primary
Rb-deficientN-ras/ thyroid tumors, all of which were calcitonin
positive (data not shown). Six cell lines were less adhesive; five
adhesive cell lines were competent for transfection and infection.
After transduction of N-Ras or N-RasV12, all of the adhesive cell
lines grew without immediate growth arrest or cell death for
a minimum of 5 days. Moreover, upon subcutaneous inoculation
into nude mice, one of the adhesive cell lines, AC61, produced
tumors histologically similar to primary Rb-deficient N-ras/
tumors. Importantly, this cell line generated smaller subcuta-
neous tumors with features of Rb-deficient adenomas when
reconstituted with N-Ras at a level comparable to that of
endogenous N-Ras expressed in the Rb-positive and ret muta-
tion-positive human C cell adenocarcinoma cell line TT (Tomoda
et al., 2008) (Figure 3A).
Nine days after N-ras transduction, we observed a marked
induction of DDR (Figure 3B). Comet assay detected a high
frequency of DNA double-strand breaks in N-Ras-transduced
cells within 10 days (Figure 3C). At day 14, we observed marked
induction of senescence markers, including recruitment of
Suv39h1, H3K9me3, and HP1g to the chromatin and induction
of p16Ink4a, p19Arf, p107, and p130 (Figures 3D and 3E). We
also detected senescence-associated heterochromatin foci
(SAHF) (Narita et al., 2003) (Figure 3D) and high SA-b-gal activity
(Figure 3F). The other four cell lines (AC55, 62, 65, and 69)
responded to N-Ras in a manner similar to AC61 (Figure S3).
We did not detect telomerase (mTERT) expression in AC61 cells.
The AC55 cell line was telomerase positive; however, N-Ras
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telomerase activity in AC55 cells, excluding the possibility of
replicative senescence (Figures S4A–S4C). These findings
indicate that in the absence of pRb, N-Ras induces DNA damage
and cellular senescence, which functions as a barrier to C cell
carcinogenesis.
p130-Dependent Differential Functions of Wild-Type
and Oncogenic N-Ras in the Absence of pRb
When introduced into AC61 cells, N-RasV12 was far less efficient
at inducing DDR and senescence markers (Figures 3B–3E),
growth arrest, and SA-b-gal activity (Figure 3F) compared to
N-Ras. Furthermore, we observed only a slight decrease in the
proliferation of pRb-reconstituted AC61 cells, suggesting that
AC61 cells were reprogrammed to no longer be addicted to Rb
loss (Figure 3F). The effects of N-Ras and N-RasV12 in inducing
cellular senescence were reversed after pRb reconstitution
(Figure 3F). These findings suggest that pRb attenuates N-Ras
function to induce cellular senescence in AC61 cells and that
N-RasV12 fails to activate alternative cellular senescence
programs when pRb is unavailable.
We observed that p130 was markedly induced and accumu-
lated in the nuclei of AC61 cells transduced with N-Ras, but
not in AC61 cells transduced with N-RasV12 (Figures 3E and
3G). Nuclear p130 was complexed with Suv39h1, H3K9me3,
and HP1g in the presence of N-Ras, but not N-RasV12
(Figure 3G). Consistent with this, we detected the colocalization
of p130 and HP1g signals in the nuclei of N-Ras-reconstituted
cells (Figure 3G). N-Ras failed to induce cellular senescence in
AC61 cells when p130 was depleted beforehand by specific
shRNAs (Figure 3H; Figure S5A). Moreover, p130 depletion at
day 14 after N-Ras transduction significantly reversed cellular
senescence (Figure 3I; Figure S5B). These findings suggest
that p130 is required for induction and maintenance of N-Ras-
induced cellular senescence in Rb-deficient cells. We also
observed significant p130 induction in primary C cell adenomas
developed in Rb+/;N-ras+/+ mice, but not in adenocarcinomas
developed in Rb+/;N-ras/ mice (Figure 3J). Taken together,
these findings suggest that induction of p130 is critical for
cellular senescence induced by N-Ras in Rb-deficient C cell
adenocarcinoma cells, and that N-RasV12 fails to induce cellular
senescence in these cells due to inability to induce p130.
Rb/;N-ras/ MEFs Escape Cellular Senescence
To generalize our observation on C cells, we characterized mouse
embryo fibroblasts (MEFs) prepared from Rb/ embryos with
various N-ras genotypes. During the serial passages according
to the 3T3 protocol (Todaro and Green, 1963), Rb/;N-ras/
MEFs achieved infinite proliferation significantly earlier than
Rb/ MEFs (Figure 4A).Rb/;Ink4a/ MEFs exhibited prolifer-
ative characteristics similar to those of Rb/;N-ras/ MEFs.
Rb/;N-ras/ MEFs, but not Rb+/+;N-ras+/+, Rb/;N-ras+/+,
or Rb+/+;N-ras/ MEFs, could form colonies when plated at low
cell density (Figure 4B). Moreover, shRNA-directed N-Ras
depletion in Rb/ MEFs allowed them to form colonies under
the same conditions (Figure 4C). Furthermore, Rb/;Ink4a/
MEFs formed colonies when plated at low cell density, which
was suppressed by p16INK4a. Colony formation by Rb/;
N-ras/ MEFs was suppressed by N-Ras, pRb, or p16INK4a,but not by N-RasV12 (Figure 4D). N-RasN17 did not reduce colony
numbers, suggesting that the function of N-Ras in colony
suppression depends on GTP. The colony suppression in Rb/;
N-ras/ MEFs induced by N-Ras was due to cellular senes-
cence (Figure 4E; Figure S6). N-RasV12 and other activated Ras
isoforms did not induce cellular senescence but induced trans-
formation inRb/;N-ras/ MEFs (Figures 4E and 4F). However,
N-RasV12 induced senescence in Rb+/+;N-ras/ MEFs
(Figure 4E) and wild-type MEFs (data not shown). A previous
study demonstrated that Rb/;p107/;p130/ MEFs escape
cellular senescence and are efficiently transformed by
H-RasV12 (Sage et al., 2000). Similarly, Rb/;N-ras/ MEFs
were transformed by all isoforms of RasV12 (Figure 4F). These
findings suggest that MEFs can be transformed by RasV12
once exempted from the senescence program and thereby
support the hypothesis that Rb/;N-ras/ MEFs escape
cellular senescence.
Finally, to further elucidate the differential functions of N-Ras
and N-RasV12 in the absence of pRb, both proteins were simul-
taneously expressed in Rb/;N-ras/ MEFs. N-Ras was domi-
nant over N-RasV12 in inducing DDR and most of the senescence
markers, but N-RasV12 antagonized N-Ras activity to induce
p16Ink4a in the absence ofRb (Figure S6). These findings suggest
that N-Ras and N-RasV12 exert many different biological func-
tions in the absence of Rb. To explain this difference, we
analyzed their activation mechanisms in the studies discussed
below.
pRb Attenuates N-Ras Activity in C Cell
Adenocarcinoma
To address why N-Ras and N-RasV12 exert different functions in
the absence of pRb, we again analyzed AC61 cells. N-Ras
expressed in AC61 cells was significantly activated; however,
the activity was decreased to 10.4% (9.6 to 1.0) when pRb was
simultaneously expressed under the influence of a strong
promoter (Figure 5A). The relative activation level of N-RasV12
(65.1) was 6.8 times higher than that of N-Ras (9.6) in the absence
of pRb. The activity of N-RasV12 was also attenuated by pRb,
but this attenuation was less efficient (65.1 to 37.5) than that
of N-Ras (9.6 to 1.0). Freshly introduced exogenous pRb was
hyperphosphorylated when coexpressed with N-RasV12
compared to N-Ras (Figure 5A), as expected from a previous
study (Peeper et al., 1997). We therefore considered that
hypophosphorylated pRb is more potent than hyperphosphory-
lated pRb in suppressing N-Ras activity. These findings suggest
that in the absence of pRb, the activation level of N-Ras is
moderate yet significantly lower than that of N-RasV12. This
may at least partially explain the differential functions of N-Ras
and N-RasV12 in the absence of pRb.
pRb Delays N-Ras Isoprenylation
To explore the mechanism of N-Ras activation control by pRb,
we transduced AC61 cells with moderately expressed pRb
using a retrovirus of known titer (1.0 multiplicity of infection).
We then transiently transduced these cells with the monomeric
VenusA207R-tagged N-Ras (Venus-N-Ras). The higher molecular
weight endowed by tagging provided us with a better separation
of proteins during SDS-PAGE. In addition, rapid analysis
immediately after completing transfection and under optimalCancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc. 259
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Rb Regulates Ras Isoprenylationconditions enabled us to detect cytosolic (unprenylated) Venus-
N-Ras proteins by immunoblotting (IB) and image analyses
before the majority of these proteins became isoprenylated. In
cells growing in 10% FBS, the moderate expression of pRb
attenuated Venus-N-Ras activity to almost half (Figure 5B).
However, under these conditions, the difference in the migration
degree of Venus-N-Ras was barely noticeable. When we
decreased FBS to 0.5% in an attempt to enhance pRb activity,
we observed an increased proportion of the unprenylated form
only in the presence of pRb. Under these conditions, the majority
of pRb was hypophosphorylated. This effect of pRb was compa-
rable to that of prenyltransferase inhibitors (PTIs) and was
reversed by 1 hr serum restimulation. However, Venus-N-Ras
activation upon serum restimulation was significantly delayed
in the presence of pRb or PTIs (Figure 5B). We observed the
same effect of pRb on N-Ras isoprenylation in another Rb-defi-
cient N-ras/ cell line (AC62) (Figure 5C). These findings
suggest that pRb delays N-Ras isoprenylation and activation.
pRb Downregulates Membrane Trafficking of N-Ras
We observed an increased proportion of unprenylated N-Ras by
IB in pRb-positive cells only when cultured under low serum
conditions. N-Ras proteins in the isoprenylated fractions
included not only those anchored to the plasma membrane but
also those anchored to endomembranes such as Golgi, endo-
plasmic reticulum, and other vesicles. Thus, a considerable
proportion of N-Ras is membrane anchored but not always
activated. Therefore, we next investigated the effects of pRb
on subcellular localization of N-Ras. We cotransfected Venus-
N-Ras and red fluorescent protein (RFP)-tagged Rab6A
(RFP-Rab6A) as a Golgi marker without the CAAX motif (Goud
et al., 1990). Twelve hours after transfection in 10% FBS,
Venus-N-Ras overlapping with RFP-Rab6A became detectable
in both pRb-negative and -positive cells (Figure 5D). We then
decreased the FBS concentration to 0.1% for 12 hr and
observed that the signal overlap was barely detectable in pRb-
positive cells, whereas it was readily detectable in pRb-negativecells. The abundance and subcellular localization of RFP-Rab6A
were not affected by pRb or by serum depletion. PTIs exhibited
the same effect as pRb during serum depletion. Under these
conditions (0.1% FBS for 12 hr), we observed that in the absence
of pRb, about half of the Venus-N-Ras was isoprenylated and
enriched in the membrane fraction, whereas in the presence of
pRb, most of the Venus-N-Ras was still unprenylated and re-
mained in the cytosolic fraction (Figure 5D). After 18 hr serum
depletion, we observed a slight recovery in the signal overlap
in pRb-positive cells. Serum restimulation enabled the recovery
of signal overlap to the initial level after 2 hr (Figure 5D). These
findings suggest that serum concentration influences the pRb
function in reducing N-Ras in Golgi at a particular time point.
Disappearance of Venus-N-Ras from Golgi can be explained
by downregulated transport to Golgi due to the decreased
isoprenylation.
Next, to examine whether delayed membrane trafficking
attenuates N-Ras activation, we observed AC61 cells cotrans-
fected with Venus-N-Ras and RFP-Rab6A using a confocal laser
microscope. After 24 hr culture in 10% FBS and subsequent
48 hr culture in 0.1% FBS, the overlap of Venus-N-Ras and
RFP-Rab6A signals was significantly higher in pRb-negative
cells than in pRb-positive cells; however, the Venus-N-Ras
signal was not detectable at the plasma membrane in either
(Figure 5E; Figure S7). Notably, 10 min after serum restimulation,
a strong Venus-N-Ras signal was detected in the periphery
of pRb-negative, but not pRb-positive, cells (Figure 5E;
Figure S7). These observations suggest that pRb delays
Venus-N-Ras transport to Golgi by attenuating endomembrane
anchoring and thereby delays further trafficking to the plasma
membrane. We further speculated that N-Ras-induced cellular
senescence in Rb-deficient C cells depends on isoprenylation,
as the N-RasSAAX (N-RasS186) mutant that cannot be isopreny-
lated completely failed to induce DDR and cellular senescence
in AC61 cells (Figure 5F) or to suppress colony formation by
Rb/;N-ras/ MEFs (data not shown). Similarly, treatment
with PTIs significantly suppressed N-Ras-induced DDR andFigure 3. Effects of N-Ras Reconstitution in Rb-Deficient N-ras/ C Cell Adenocarcinoma
(A) Top: immunoblot (IB) analysis of TT and AC61 cells infected with pBabe-puro (vector) or pBabe-puro-N-Ras for the indicated proteins. Middle: histological and
IHC analysis of AC61 cells infected with pBabe-puro or pBabe-puro-N-Ras, selected, and cultured subcutaneously in BALB/c-nu/nu mice for 14 days. Bottom:
primary C cell tumors from mice of the indicated genotype. Scale bars = 100 mm. Right: quantification of tumor weights and frequency of immunostain-positive
cells per 200 tumor cells. Bars show mean + SEM from n = 4 tumors each.
(B) Immunofluorescence (IF) analysis of AC61 cells infected with pBabe-puro vectors expressing the indicated proteins, selected, and cultured for additional
8 days. DAPI (blue) was used to visualize nuclei. Scale bars = 10 mm.
(C) Comet assay of cells in (B). Scale bars = 30 mm. Percentage of cells with DNA double-strand breaks is quantified below. Numbers show mean ± SEM from
three experiments.
(D) IF analysis of cells prepared as in (B) and cultured for additional 12 days. Scale bars = 10 mm.
(E) IB of acid-extracted (gH2AX, Suv39h1, H3K9me3, and HP1g) or whole-cell (others) lysates from cells prepared as in (B) and cultured for an additional 9 days.
NT, nontreated; H2O2, treated with 200 mM H2O2 for 30 min at 4
C; SS, serum starved in 0.1% FBS for 24 hr.
(F) Top: AC61 cells were infected with pBabe-puro vectors expressing the indicated proteins and selected. Bottom: AC61 cells infected with pLXSB or pLXSB-Rb
and selected were reinfected with pBabe-puro vectors expressing the indicated proteins and selected. Cell proliferation was monitored from day 6 onward, and
SA-b-gal activity was detected at day 11 after the last infection. Scale bars = 30 mm.
(G) Left: immunoprecipitation (IP) from whole-cell lysates (WCL) or chromatin fraction (CH) of cells prepared as in (B) and cultured for additional 9 days. Upper
bands show HP1g bound to p130 or Suv39h1 in the chromatin fraction. Right: colocalization of p130 and HP1g in these cells. Scale bars = 5 mm.
(H) AC61 cells were infected with lentiviruses expressing the indicated shRNAs and selected with puromycin. Five days after the initial infection, cells were
reinfected with pLXSB or pLXSB-N-Ras, selected, and analyzed. BrdU incorporation as determined by fluorescence-activated cell sorting (FACS) and IB at
day 6 after the last infection is shown. Bars show mean + SEM from duplicate experiments.
(I) AC61 cells were transduced with the indicated shRNAs 14 days after N-Ras transduction and analyzed as in (H). Bars show mean + SEM from duplicate
experiments.
(J) IHC analysis of thyroids or primary C cell tumors in mice of the indicated genotypes. Scale bars = 100 mm. Quantification at right was performed as in Figure 1B.
Bars show mean + SEM (nR 20 each).Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc. 261
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Figure 4. Rb-N-ras Genetic Interaction in MEFs
(A) 3T3 protocol assay of mouse embryonic fibroblasts (MEFs) of the indicated genotypes. Cumulative multiplicity in representative cultures at the indicated
passage number is shown.
(B) Representative results of colony formation assays of MEFs of the indicated genotypes plated at low density. Results are quantified below. Bars show mean +
SEM (n = 6).
(C) Top:Rb/MEFs infected with lentiviruses expressing the indicated shRNAs, selected, plated at low density, reinfected every 5 days three times, and cultured
for 21 days from the initial infection. Bottom: IB analysis of cells infected once with the indicated lentiviruses.
(D) Colony suppression assay of MEFs of the indicated genotypes cotransfected with pLXSB and pBabe-puro vectors expressing the indicated proteins and
selected. Bars show mean + SEM (n = 4).
(E) SA-b-gal assay of MEFs of the indicated genotypes infected with pBabe-puro vectors expressing the indicated proteins, selected, and cultured for 9 days.
Scale bars = 100 mm.
(F) Proliferation of MEFs of the indicated genotypes infected with pBabe-puro vectors expressing the indicated proteins or pMIKcys (K-RasV12). After selection,
1 3 105 viable cells were plated on 100 mm dishes (day 6), and cell number was counted at the indicated time points.cellular senescence in AC61 cells (Figure 5G). Finally, we exam-
ined whether Rb loss increases N-Ras isoprenylation. Venus-
N-Ras was introduced into Rb+/+ and Rb/ MEFs. Upon serum
starvation initiated 8 hr after transfection, Rb/ MEFs exhibited
faster isoprenylation of Venus-N-Ras protein compared to
littermate Rb+/+ MEFs (Figure 5H; Figure S8), suggesting that
Rb loss in MEFs accelerates N-Ras isoprenylation.262 Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc.pRb Downregulates Genes Involved in Isoprenylation
A previous study demonstrated that the influence of pRb on Ras
activity depends on de novo protein synthesis (Lee et al., 1999).
We therefore performed microarray analysis on AC61 cells
freshly transduced with moderately expressed pRb. These cells
were maintained unsynchronized in 10% FBS, which allowed the
cells to attenuate N-Ras activity to half (Figure 5B). Genes
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Rb Regulates Ras Isoprenylationsignificantly upregulated by pRb included many cell surface anti-
gens, lymphokines, interferons, and inflammation-related genes
(Figure S9), similar to previous results obtained by analyzing
MEFs conditionally lacking pRb (Markey et al., 2007). Moreover,
in genes significantly downregulated by pRb, we detected
known E2F targets such as Cdc6, N-myc, and Mmp-3 with the
highest statistical significance (change p value > 0.99998 as
determined by Wilcoxon’s signed rank test), suggesting that
pRb reconstitution was successful (Table S1).
In 396 significantly upregulated genes (change p value < 0.001),
we did not detect genes that could be directly involved in sup-
pressing Ras activity such as GTPase-activating protein (Gap).
In 270 significantly downregulated genes (change p value >
0.9998), we found that farnesyl diphosphate farnesyltransferase
1 (Fdft1) had the highest rank (Table S1). In addition, we detected
a number of genes (Table S2) predicted to be transactivated by
sterol regulatory element-binding proteins (SREBPs) via sterol
regulatory element (SRE) (Sakakura et al., 2001). Other genes
that could be directly involved in stimulating Ras activation,
such as GTP exchange factor (Gef) or receptor tyrosine kinase
(Rtk), were not detected. We then analyzed pRb-reconstituted
AC61 cells by RT-PCR. Surprisingly, in addition to Fdft1, farnesyl
diphosphate synthase (Fdps) (Szkopinska and Plochocka, 2005),
most of the prenyltransferases (farnesyltransferase a [Fnta],
farnesyltransferase b [Fntb], protein geranylgeranyltransferase
1b [Pggt1b], and Rab geranylgeranyltransferase b [Rabggtb])
(Maurer-Stroh et al., 2003), and SREBP-1 and SREBP-2 were
significantly downregulated by pRb. All of these genes were
induced in MEFs following Rb loss or pRb inactivation using
SV40 large T antigen or adenovirus E1A (Figure 6A). A farnesyl-
transferase b immunoblot validated the RT-PCR results (Fig-
ure 6B). We did not detect a significant change in expression of
NF1 (Courtois-Cox et al., 2006) (data not shown).
To investigate the in vivo relevance of the increased expression
of genes involved in protein isoprenylation in Rb-deficient cells,
primary Rb-deficient C cell adenomas were immunohistochemi-
cally analyzed. These tumors expressed significantly higher
levels of Fntb, SREBP-1, and SREBP-2 compared to normal
thyroid tissue (Figure 6C). We then compared the expression
levels of these proteins between pRb-positive ret mutation-posi-
tive human medullary thyroid carcinoma cell line TT (Tomoda
et al., 2008) and AC61. AC61 cells expressed significantly higher
levels of Fnta, Fntb, SREBP-1, and SREBP-2 compared to TT
cells (Figure S10).
E2F-Dependent TranscriptionControl of Genes Involved
in Isoprenylation
To further investigate the mechanism bywhich pRb controlsgenes
involved in protein isoprenylation, we analyzed the promoter
regions of these genes. We detected several E2F-binding
consensus sequences in the promoter regions of SREBPs
(Figure S11). Moreover, we detected several E2F-binding
consensus sequences in each of the promoters of Fdps and
prenyltransferases. These findings suggest that E2Fs control
Fdps and prenyltransferases via a dual mechanism involving
SREBPs and direct binding. Chromatin immunoprecipitation
(ChIP) assay detected the direct binding of E2F-1 and E2F-3 to
the promoters of these genes specifically in the absence of pRb
(Figure 6D). E2F-3 exhibited stronger DNA-binding activity to theFntb promoter than E2F-1 did. We also detected direct binding
ofpRb to theFdpspromoter. pRb prevented SREBPs frombinding
to the Fdps promoter, probably via downregulation of SREBPs.
Furthermore, a pRb mutant derived from a retinoblastoma and
lacking the ability to attenuate Ras activation (Lee et al., 1999)
could not bind to the Fdps promoter and did not suppress SREBP
binding. However, a partially penetrant mutant pRb (Sellers et al.,
1998) with the ability to attenuate Ras activation (Lee et al., 1999)
bound to the Fdps promoter and suppressed SREBP binding
(Figure S12), suggesting that the function of pRb in attenuating
Ras activation is not separable from its ability to regulate the
Fdps promoter and SREBPs.
Fdps, Fntb, and SREBP-1 promoters were downregulated by
pRb. This effect was augmented by serum depletion. These
promoters were upregulated by either E2F-1 or E2F-3
(Figure 6E). In particular, E2F-3 was more potent than E2F-1 in
transactivating the Fntb promoter, in agreement with the ChIP
results (Figure 6D). The truncated mutant E2F containing the
DNA-binding domain but lacking the transactivation domain
(E2F-DB) slightly but significantly downregulated these
promoters, suggesting the involvement of liberated E2Fs in the
basal transactivation. Fdps and SREBP-1 promoters were upre-
gulated by SREBP-1c, but the Fntb promoter, which lacks SRE,
was not. The dominant-negative SREBP-1c downregulated the
basal transactivation of these two promoters, indicating
increased endogenous SREBP activity in AC61 cells. Further-
more, these three promoters were downregulated by pRb in
two other pRb-negative cell lines (Rb/;N-ras/ MEFs and
Saos2). Transduction of E2F-DB, SV40 large T antigen, or
adenovirus E1A in MEFs induced Fdps promoter transactivation
(Figure 6E). E2F-DB is known to affect the functions of E2Fs in
multiple ways; one is derepression of active transcriptional
silencing by the pRb-E2F complex (Rowland et al., 2002).
Thus, we considered that the pRb-E2F complex directly partici-
pates in the transcriptional repression of Fdps.
pRb-Dependent Protein Farnesylation
The CAAX motif constitutes a C-terminal tetrapeptide common
to all Ras proteins, directing multistep posttranslational modifi-
cations initiated by farnesyltransferases (Hancock, 2003). There
are approximately 300 proteins with the CAAX motif that are
potentially farnesylated. To investigate pRb’s effects on these
proteins, we analyzed AC61 cells or MEFs metabolically labeled
with [3H]farnesol. In 10% FBS, pRb-negative cells showed an
increased density of farnesylated protein bands. When serum
was depleted, this difference became greater (Figure 6F;
Figure S13). These findings suggest that Rb loss induces
enhanced global protein farnesylation.
Clinical Relevance of the pRb-N-Ras Pathway
in Medullary Thyroid Carcinomas
Human medullary thyroid carcinomas (MTCs) are pathologically
similar to the C cell adenocarcinomas in the mice analyzed in this
study. Human C cell adenoma is extremely rare. Familial MTCs
are frequently associated with mutation in the ret oncogene;
however, almost half of sporadic MTCs are free of the ret
mutation (Marsh et al., 2003), indicating a ret-independent
mechanism involved in human C cell carcinogenesis. To address
the relevance of the pRb-N-Ras pathway in human tumors, weCancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc. 263
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Figure 5. Effects of pRb on N-Ras Isoprenylation and Membrane Trafficking
(A) AC61 cells transfected with 0.25 mg pBabe-puro-N-Ras or pBabe-puro-N-RasV12 together with 2.5 mg pSG5 or pSG5L-HA-Rb were selected and analyzed
for GTP-bound N-Ras or status of the indicated proteins in the presence of 10% FBS. Pull-down of GTP-loaded N-Ras was performed using glutathione
S-transferase (GST)-fused Ras-binding domain (RBD) of Raf. N-Ras-GTP:total ratio in the presence of N-Ras and pRb (lane 2) was set to 1.0, and relative
N-Ras activity in other lanes was estimated.
(B) AC61 cells infected with pLXSB or pLXSB-Rb and selected were transiently transfected with pCAGGS-VenusA207R-N-Ras, treated under the indicated condi-
tions, and analyzed for N-Ras prenylation status (top three rows) and activity (bottom three rows). PTIs = mixture of prenyltransferase inhibitors (FTI-II and FTI-277264 Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc.
Cancer Cell
Rb Regulates Ras Isoprenylationanalyzed 13 sporadic MTC cases, of which 6 (46%) were immu-
nohistochemically negative for pRb and 7 (54%) were negative
for N-Ras (Figure 7A). Notably, 6 of 7 N-Ras-negative tumors
were negative for pRb (Figure 7B). This finding in human
sporadic MTC is consistent with the requirement of N-Ras
suppression in Rb-deficient C cell carcinogenesis in mice.
DISCUSSION
The current work provides evidence that in the absence of pRb,
E2F-1 and E2F-3 participate in the transactivation of most of the
genes involved in protein isoprenylation either directly or via
SREBPs. This at least partially explains the Ras activity elevation
induced by pRb inactivation (Figure S14A). It would be of interest
to ascertain whether under physiological conditions, Ras
and pRb activities oscillate due to mutual suppression via cyclin
D/Cdk4/6 and E2F/isoprenylation (Figure S14B). Furthermore,
this study partially clarifies the mechanism of the tumor
suppressor function of wild-type Ras. It has previously been
shown that loss of the normal ras allele, in addition to activating
mutation, is required for tumorigenesis (see references in Zhang
et al., 2001). This study indicates that N-Ras and N-RasV12 exert
different functions in Rb-deficient cells where only N-Ras can
induce p130-dependent cellular senescence, which explains
why N-RasV12 requires pRb to induce cellular senescence.
Cell-cycle-dependent Ras activation was noted by Taylor and
Shalloway (1996). Later, it was determined that pRb inactivation
(Raptis et al., 1997) or genetic loss (Lee et al., 1999) elevates Ras
activity. The latter study observed that high N-Ras activation was
sharply induced in serum-starved Rb/ MEFs only 10 min after
serum restimulation. We suspect that during serum starvation,
pRb-negative cells pool greater numbers of N-Ras-GDP mole-
cules in the space where GDP to GTP exchange readily occurs
upon serum restimulation. Indeed, our results suggest that iso-
prenylated Ras-GDP proteins are aberrantly enriched in the
Golgi complex in pRb-negative cells during serum starvation.
At Golgi, Ras is activated through Src-mediated activation of
phospholipase Cg. The nature of Ras signaling generated from
Golgi is supposed to be distinct from that generated from the
plasma membrane in terms of activation of JNK, ERK, AKT,
and Ral pathways (Hancock, 2003; Quatela and Philips, 2006).
Therefore, in addition to moderate-level activation, enrichmentof N-Ras in Golgi in Rb-deficient cells may assign a specific
role to itself.
Simultaneous N-ras or K-ras deletion rescues differentiation
defects inRb null embryos and prolongs life span with no detect-
able impact on E2F-dependent ectopic proliferation and
apoptosis (Takahashi et al., 2003, 2004). This is in line with our
observation that the isoprenylation-dependent regulation of
Ras activation is genetically downstream of E2Fs in the absence
of pRb (Figure S14A). The limited effect of E2F deletion on differ-
entiation defects in Rb/ embryos can be explained by the
redundant functions shared by E2F family members. Indeed,
deletion of individual E2Fs in Rb/ embryos results in varying
degrees of rescue of erythropoiesis (Wikenheiser-Brokamp,
2006; Dirlam et al., 2007). The extended life span of Rb-deficient
embryos achieved by additionally deleting N-ras was apparently
due to the rescue of hepatic anemia (Takahashi et al., 2003).
Although the etiology ofRb-deficient anemia is still controversial,
a significant genetic interaction seems to exist between E2Fs
andN-ras inRb-mediated erythropoiesis. Furthermore, common
C cell tumor phenotypes in Rb+/;E2F3/ and Rb+/;N-ras/
mice, the senescence-inducing activity of E2F-3 in vivo (Lazzer-
ini Denchi et al., 2005), and the role of E2F-3 in regulating the
transcription of genes involved in Ras isoprenylation (this study)
suggest that E2F3 and N-ras are genetically linked in Rb-defi-
cient C cell carcinogenesis.
Our observation of less frequent senescence markers,
compared to DDR, in early Rb-deficient adenomas indicates that
DDR chronologically precedes the appearance of senescence
markers during adenoma formation.However, thisdoesnot neces-
sarily mean thatRb loss-induced DNA damage is a prerequisite for
inducing cellular senescence. To further address this issue, we are
analyzing Rb+/;ATM/ mice (A.S. and C.T., unpublished data).
The RB pathway has been linked to DDR through E2F-dependent
pathways (Pickering and Kowalik, 2006) involving cyclin E (Tort
et al., 2006) or Mad2 (Hernando et al., 2004). Our study proposes
that N-Ras or other isoprenylated proteins may participate in
accumulating DNA double-strand breaks in Rb-deficient cells.
This study also elucidates the tumor suppressor roles of p130,
p16Ink4a, Arf, and Suv39h1 in the absence of pRb. Despite the
role of p53 in human retinoblastoma, Rb+/;p53+/ mice
generate C cell adenocarcinoma at a lower frequency (8%)
following spontaneous mutation in the ret oncogene (Coxon
et al., 1998) compared to Rb+/;N-ras/ mice (91.6%). Thisat 10 mM and GGTI-298 at 2 mM). Unprenylated (UP) and prenylated (P) Venus-N-Ras proteins are indicated by arrows. The status of transduced pRb in each
condition is indicated at right.
(C) Another Rb-deficient N-ras/ C cell tumor line, AC62, was analyzed in 0.5% FBS as in (B).
(D) Top: AC61 cells prepared as in (B) and cotransfected with pCAGGS-VenusA207R-N-Ras (green) and pCXN2-RFP-Rab6A (red) were monitored using
fluorescence microscopy under the indicated conditions. Scale bars = 40 mm. Merged signals (arrows) are shown. Bottom left: relative intensity of signals in Golgi
(RFP-Rab6A-positive area) was measured using NIH ImageJ 1.4 and quantified at the indicated time points. Results show mean ± SEM from 90 cells observed in
three experiments. Bottom right: cells cultured in 0.1% FBS for 12 hr were lysed and fractionated. C, cytosolic; M, membranous; W, whole-cell lysates.
(E) Top: AC61 cells were cotransfected with 0.25 mg pCAGGS-VenusA207R-N-Ras (green) and 0.25 mg pCXN2-RFP-Rab6A (red) together with 2.5 mg pCMV or
pCMV-Rb. Cells were grown in 10% FBS for 24 hr, serum starved in 0.1% FBS for an additional 48 hr, restimulated with 10% FBS, and analyzed at the indicated
time points using a laser confocal fluorescence microscope. Scale bars = 10 mm. Bottom: signal intensity of Venus-N-Ras in the cell periphery was measured
using NIH ImageJ 1.4 and quantified from observation of 50 cells each. Bars show mean + SEM from three experiments.
(F) AC61 cells were transfected with pBabe-puro, pBabe-puro-N-Ras, or pBabe-puro-N-RasS186; selected; and analyzed after 12 days.
(G) AC61 cells were transfected with pBabe-puro or pBabe-puro-N-Ras; selected; treated with 2.5 mM FTI-II, 2.5 mM FTI-277, and 0.5 mM GGTI-298 (PTIs) or with
vehicle (DMSO); and analyzed as in (F). Amido black stain is shown as a loading control.
(H) Paired MEFs of the indicated genotypes were transfected with Venus-N-Ras for 8 hr, grown under 0.5% FBS for 24 hr or treated with PTIs as in (G), and
analyzed. Prenylated and unprenylated fractions of total Venus-N-Ras are quantified below. Another pair of MEFs is shown in Figure S8.Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc. 265
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Figure 6. E2F-Dependent Transcriptional Control of Enzymes Involved in Protein Isoprenylation
(A) RT-PCR of the indicated genes in AC61 cells infected with pLXSB or pLXSB-Rb and pBabe-puro or pBabe-puro-N-Ras in the indicated combinations and
selected; MEFs infected with pBabe-neo-TAg or control vector;Rb+/+ andRb/MEFs cultured in 0.1% FBS for 24 hr; or MEFs infected with pBabe-hygro-E1A or
vector control and selected. SV40LT, simian virus 40 large T antigen; E1A, adenovirus E1A.
(B) IB of farnesyltransferase b in AC61 cells expressing the indicated protein and in Rb/ and Rb+/+ MEFs.
(C) IHC analysis of wild-type thyroids and Rb-deficient C cell adenomas. Scale bars = 100 mm. Quantification at right was performed as in Figure 1B.
(D) ChIP assay of the indicated gene promoters in AC61 cells infected with pLXSB or pLXSB-Rb. Positions and sequences of the primers in the mouse genome are
shown in Figure S11 and Table S4.
(E) Luciferase activity in the indicated cell types transfected with pGL3 containing the indicated luciferase reporters together with pCMV-b-gal and the expression
vectors pSG5L-HA-Rb, pcDNA3-HA-E2F-1, pcDNA3-HA-E2F-3, pBabe-puro-E2F-DB, pSV-Sport-SREBP-1c, pSV-Sport dominant-negative (DN)-SREBP-1c,
pBabe-neo-Tag, or pBabe-hygro-E1A. Empty vectors (control) were used under the same conditions; results are normalized to b-gal activity and shown as
controls set to 1.0. Bars show mean + SEM (nR 3).
(F) Visualization of [3H]farnesylated proteins in AC61 cells prepared as in (D) and treated under the indicated conditions. Coomassie staining is shown as a loading
control.suggests that, particularly in C cells, the lower p53 activity
acts independently to increase genomic instability rather than
intimately cooperating with the RB pathway.266 Cancer Cell 15, 255–269, April 7, 2009 ª2009 Elsevier Inc.Our study also explains the tumor-promoting function of wild-
type Ras observed in Rb-deficient pituitary glands (Takahashi
et al., 2004, 2006) and immortalized fibroblasts (Raptis et al.,
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cence is known to occur in limited cell types, but activated Ras
promotes carcinogenesis in many cell types. Furthermore, not
only Ras but also other isoprenylated proteins including many
small GTPase proteins, CENP-E, and CENP-F (Maurer-Stroh
et al., 2003) may be orchestrated by pRB via E2Fs. We have
previously detected upregulated RhoA, Rac, and Cdc42 activity
in Rb-deficient cells (Takahashi et al., 2006). Finally, we empha-
size that our study provides a rational basis for applying PTIs to
pRB-inactivated tumors without somatic ras mutations such as
retinoblastomas, osteosarcomas, and small cell lung carci-
nomas.
EXPERIMENTAL PROCEDURES
Animals
Rb+/ mice with various N-ras genotypes were described previously (Takaha-
shi et al., 2006). Rb+/ mice were crossed with Ink4a/, Arf/, Ink4a/;
Arf/, or Suv39h1/ mice, and the resultant progeny were intercrossed to
generate mice used in this study. Average age at examination (AE) was deter-
mined irrespective of mouse status. Mouse genotyping is described in the
Supplemental Experimental Procedures. The protocol of this study was
approved by the ethical committee of Kyoto University Graduate School of
Medicine, and animals were handled in accordance with the guidelines of
Kyoto University.
Cell Culture
Primary C cell adenocarcinoma cell lines were established as described
previously (Takahashi et al., 2006), with minor modifications. MEFs were
prepared from E12.5 embryos derived by intercrossing Rb+/;N-ras+/ or
Rb+/;Ink4a+/ mice.
Figure 7. Analysis of Human Sporadic Medullary Thyroid Carci-
nomas
(A) IHC analysis of human sporadic medullary thyroid carcinomas (MTCs).
Of 13 cases analyzed, representative cases are shown. Scale bars = 100 mm.
(B) Chi-square analysis (Fisher’s exact test) showing the correlation between
pRB and N-Ras expression in 13 sporadic human MTCs. p = 0.001998;
c2 = 9.55.Comet Assay
CometAssay reagent kit was purchased from Trevigen (4250-050-K).
RNA Interference
MISSION TRC shRNA target sets (TRCN 71271 and 71274 for p130; 34391,
34392, and 34393 for N-Ras) and TurboGFP shRNA control vector (SHC004)
were purchased from Sigma-Aldrich.
BrdU incorporation
BrdU incorporation was measured as described previously (Takahashi et al.,
2004).
Colony Formation Assays
Colony formation was assessed by plating 13 103 cells per 60 mm dish. After
14 days cultivation, Giemsa staining was used to visualize colonies. Suppres-
sion of colony formation was observed by transfecting 1 3 105 MEFs with
0.5 mg pLXSB and 5 mg pBabe-puro expressing the indicated proteins,
followed by 14 days cultivation with 8 mg/ml blasticidin S.
Ras Activation Assay
Pull-down assay to measure N-Ras activity was performed as described
previously (Lee et al., 1999).
Prenylation Assay
Cells transiently transfected with pCAGGS-VenusA207R-N-Ras were lysed as
described previously (Miki et al., 2007), sonicated for three cycles of 15 s
each, and separated on 8%–10% acrylamide SDS-PAGE gel at a low constant
voltage (less than 40V for longer than 36 hr). FTI-I (#344150), FTI-277
(#344555), and GGTI-298 (#345883) were purchased from Calbiochem.
RT-PCR
Total RNA was extracted using a QIAGEN RNeasy Mini Kit (74104), and
RT-PCR was performed using a TaKaRa RNA PCR Kit (RR019A) and the
sequence-specific primers indicated in Table S3.
Chromatin Immunoprecipitation
ChIP reagents (SC-45000, 45001, 45002, and 45003) were purchased from
Santa Cruz Biotechnology. Lysates were reacted with specific antibodies for
immunoprecipitation. Released DNA was amplified by PCR using the primers
indicated in Table S4.
Global Farnesylation Assay
5 3 106 cells were cultured in 10% FBS with 10 mM lovastatin for 4 hr. After
lovastatin was removed, the cells were incubated with 1.54 MBq [3H]farnesol
in the presence of 10% FBS for 4 hr and then in the presence of 10% or 0.5%
FBS for an additional 20 hr. Labeled proteins were analyzed as described
previously (Andreas et al., 1999).
Human Tumors
Tumors from patients with sporadic MTC were surgically removed at the
Department of Endocrine Surgery and diagnosed at the Department of
Pathology, Tokyo Women’s Medical University. The protocol of this study
was approved by the ethical committee of Tokyo Women’s Medical University,
and informed consent was obtained from all patients.
ACCESSION NUMBERS
Microarray data described herein have been deposited at the NCBI Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under the accession
number GSE12637.
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Supplemental References, fourteen figures, and four tables and can be found
with this article online at http://www.cancercell.org/supplemental/
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